Impaired endothelial progenitor cell activity is associated with reduced arterial elasticity in patients with essential hypertension

Clinical and Experimental Hypertension

Volumn 32, Issue 7, 2010, Pages 444-452

  Yang, Zhen ^a   Chen, Long ^a   Su, Chen ^a   Xia, Wen Hao ^a   Wang, Yan ^a   Wang, Jie Mei ^a   Chen, Fei ^a   Zhang, Yuan Yuan ^a   Wu, Fang ^a   Xu, Shi Yue ^a   Zhang, Xiao Lin ^a   Tao, Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Arterial elasticity; Endothelial function; Endothelial progenitor cells; Endothelium; Hypertension

Indexed keywords

ADULT; ARTICLE; CELL ACTIVITY; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELASTICITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FLOW CYTOMETRY; HUMAN; MULTIVARIATE ANALYSIS; PULSE WAVE; STEM CELL; SYSTOLIC BLOOD PRESSURE;

ARTERIES; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; CHOLESTEROL; ELASTICITY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; STEM CELLS;

EID: 78049459657     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641961003686435     Document Type: Article

References (39)

1. Cohn JN. Arterial stiffness, vascular disease, and risk of car-diovascular events. Circulation 2006;113:601-603.
2. Cohn JN, Duprez DA, Grandits GA. Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment. Hypertension 2005;46:217-220.
3. Franklin SS. Arterial stiffness and hypertension: a two-way street? Hypertension 2005;45: 349-351.
4. Laurent S. Surrogate measures of arterial stiffness: do they have additive predictive value or are they only surrogates of a surrogate? Hypertension 2006;47:325-326.
5. Abdelhammed AI, Smith RD, Levy P, Smits GJ, and Ferrario CM. Noninvasive hemodynamic profiles in hypertensive Subjects. Am J Hypertens 2005;18:51S-59S.
6. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:932-943.
7. Boos CJ, Goon PKY and Lip GYH. Endothelial progenitor cells in the vascular pathophysiology of hypertension: arterial stiffness, ageing and more. J Hum Hypertens 2006; 21:521-523.
8. Wilson AM, Neal DO, Nelson CL, Prior DL, Best JD, and Jenkins AJ. Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens 2004; 17:285-291.
9. Aicher A, Andreas MZ, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005;45:321.
10. Wang JM, Huang YJ, Wang Y, Xu MG, Wang LC, Wang SM, Tao J. Increased circulating CD31+/CD42-microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens 2007;20:957-964.
11. Tao J, Wang Y, Yang Z, Tu C, Xu MG, Wang JM. Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. J Hum Hypertens 2006;20:490-495.
12. Imanishi T, Moriwaki C, Hano T and Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005;23:1831-1837.
13. Hill, JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 2003; 348: 593-600.
14. Pirro M, SchillacG, Menecali C, Bagaglia F, Paltriccia R, Vaudo G, Mannarino MR and Mannarino E. Reduced num-ber of circulating endothelial progenitors and HOXA9 expres-sion in CD34+ cells of hypertensive patients. J Hypertens 2007;25:2093-2099.
15. Zonneveld Anton-Jan van and Rabelink TJ. Endothelial pro-genitor cells: biology and therapeutic potential in hypertension. Curr Opinion Nephrol Hypertens 2006;15:167-172.
16. Yao EH, Fukuda N, Natsumoto T, Katakawa M, Yamamoto C, Han Y, Ueno T, Kobayashi N, Katakawa K. Effects of the antioxidative beta-blocker celiprolol on endothelial pro-genitor cells in hypertensive rats. Am J Hypertens 2008;21: 1062-1068.
17. Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rossig L, Spyridopoulos I, Zeiher AM, Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase pro-liferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003;92:1049-1055.
18. Ablin JN, Boquslavski V, Aloush V, Elkayam O, Paran D, Caspi D, George J. Effect of anti-TNF alpha treatment on cir-culating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 2006;79:2364-2369.
19. Colleselli D, Bijuklic K, Mosheimer BA, Kahler CM. Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation. Exp Cell Res 2006;312:2933-2941.
20. McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM, Cohn JN. Agerelated abnor-malities in arterial compliance identified by pressure pulse contour analysis; aging and arterial compliance. Hypertension 1999;33:1392-1398.
21. Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003;16:653-657.
22. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Mar-tin H, Zeiher A, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:e1-e7.
23. Tao J, Yang Z, Wan JM, Tu C, Pan SR. Effects of fluid shear stress on eNOS mRNA expression and NO production in human endothelial progenitor cells. Cardiology 2006;2: 82-88.
24. Yang Z, Tao J, Wang JM, Tu C, Xu MG, Wang Y, Pan SR. Shear stress contributes to t-PA mRNA expression in human endothelial progenitor cells and nonthrombogenic potential of small diameter artificial vessels. Biochem Biophys Res Commun 2006;342:577-584.
25. Yang Z, Wang JM, Wang LC, Chen L, Tu C, Luo CF, Tang AL, Wang SM, Tao J. In vitro shear stress modulates anti-thrombogenic potentials of human endothelial progenitor cells. J Thromb Thromboly 2007;23:121-127.
26. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in Agerelated endothelial dys-function. J Am Coll Cardiol 2005;45:1441-1448.
27. Sandri MB, Adams V, Gielen S, Linke A, Lenk K, Kränkel N, Lenz D, Erbs S, Scheinert D, Mohr FW, Schuler G, Hambrecht R. Effects of exercise and ischemia on mobilization and func-tional activation of blood-derived progenitor cells in patients with ischemic syndromes: Results of 3 randomized studies. Circulation 2005;111:3391-3399.
28. Rietzschel ER, Boeykens E, Buyzere ML, Duprez DA, Clement DL. A comparison between systolic and diastolic pulse con-tour analysis in the evaluation of arterial stiffness. Hypertension 2001;37:15-22.
29. Yu WC, Chuang SY, Lin YP, Chen CH. Brachialankle vs carotid-femoral pulse wave velocity as a determinant of cardio-vascular structure and function. J Hum Hypertens 2008;22: 24-31.
30. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avog-aro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008; 197:496-503.
31. Oliveras A, Soler MJ, Martinez-Estrade OM, Vazquez S, Macro-Feliu D, Vila JS, Vilaro S, Lloveras J. Endothelial pro-genitor cells are reduced in refractory hypertension. J Hum Hypertens 2007;28:721-727.
32. DelvaP, DeganM, VallerioP, Arosio E, Minuz P, AmenG, ChioMD and Lechi A. Endothelial progenitor cells in patients with essential hypertension. J Hypertens 2007; 25:127-132.
33. Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY. Improvement in endothelial progenitor cells from peripheral blood by rami-pril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2004;18:203-209.
34. Yang Z, Wang JM, Chen L, Luo CF, Tang AL and Tao J. Acute exercise-induced nitric oxide production contributes to upregulation of circulating endothelial progenitor cells in healthy subjects. J Hum Hypertens 2007;21:452-460.
35. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997;349:837-842.
36. Alexandra A, Christopher H and Dimmeler S. The role of NOS3 in stem cell Mobilization. Trends In Mol Med 2004; 10:421-425.
37. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-1923.
38. Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005;23:97-104.
39. Belgore FM, Blann AD, Li-Saw-Hee FL, Beevers DG, and Lip GYH. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. Am J Cardiol 2001;87:805-807.